MoneyWorks4Me

Kilpest India’s arm completes acquisition of 70% stake in HS Biolabs

29 Mar 2022 Evaluate

Kilpest India’s subsidiary company -- 3B BlackBio Biotech India has completed the acquisition of 70% equity stake in HS Biolabs, Manchester, United Kingdom. With this, HS Biolabs has become subsidiary company of 3B BlackBio Biotech India and step down subsidiary company of the company.

This transaction will accelerate the manufacturing, R&D, marketing and sales processes in the UK which would give much higher product acceptability / reach to the company’s products, especially in Europe for the ‘Made in UK’ products. With the R&D and manufacturing in the UK, the company’s brand image in MDx segment would increase substantially.

Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.

Peers
Company Name CMP
Lenskart Solutions 686.85
Poly Medicure 1674.95
Molbio Diagnostics 1309.45
Laxmi Dental 191.50
GKB Ophthalmics 64.00
View more..